187 related articles for article (PubMed ID: 31703396)
21.
Liu YY; Yang ZX; Ma LM; Wen XQ; Ji HL; Li K
PeerJ; 2019; 7():e8151. PubMed ID: 31803539
[TBL] [Abstract][Full Text] [Related]
22. Urinary metabolomic analysis of intrahepatic cholestasis of pregnancy based on high performance liquid chromatography/mass spectrometry.
Ma L; Zhang X; Pan F; Cui Y; Yang T; Deng L; Shao Y; Ding M
Clin Chim Acta; 2017 Aug; 471():292-297. PubMed ID: 28669684
[TBL] [Abstract][Full Text] [Related]
23. Novel Metabolic Signatures of Prostate Cancer Revealed by
Yang B; Zhang C; Cheng S; Li G; Griebel J; Neuhaus J
Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33498542
[TBL] [Abstract][Full Text] [Related]
24. Metabolomic markers of healthy dietary patterns in US postmenopausal women.
McCullough ML; Maliniak ML; Stevens VL; Carter BD; Hodge RA; Wang Y
Am J Clin Nutr; 2019 May; 109(5):1439-1451. PubMed ID: 31051511
[TBL] [Abstract][Full Text] [Related]
25. Pattern recognition analysis for hepatotoxicity induced by acetaminophen using plasma and urinary 1H NMR-based metabolomics in humans.
Kim JW; Ryu SH; Kim S; Lee HW; Lim MS; Seong SJ; Kim S; Yoon YR; Kim KB
Anal Chem; 2013 Dec; 85(23):11326-34. PubMed ID: 24127682
[TBL] [Abstract][Full Text] [Related]
26. Exploring potential biomarkers of early stage esophageal squamous cell carcinoma in pre- and post-operative serum metabolomic fingerprint spectrum using
Yang Z; Liu Y; Ma L; Wen X; Ji H; Li K
Am J Transl Res; 2019; 11(2):819-831. PubMed ID: 30899382
[TBL] [Abstract][Full Text] [Related]
27. UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.
Wang Z; Liu X; Liu X; Sun H; Guo Z; Zheng G; Zhang Y; Sun W
BMC Cancer; 2019 Dec; 19(1):1195. PubMed ID: 31805976
[TBL] [Abstract][Full Text] [Related]
28. Urine Untargeted Metabolomic Profiling Is Associated with the Dietary Pattern of Successful Aging among Malaysian Elderly.
Nik Mohd Fakhruddin NNI; Shahar S; Ismail IS; Ahmad Azam A; Rajab NF
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32977370
[TBL] [Abstract][Full Text] [Related]
29. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
30. [Discrimination of patients with Xiao-Chaihu Tang syndrome using 1H NMR metabonomics and partial least square analysis].
Xing J; Yuan SC; Sun HM; Fan ML; Li ZY; Qin XM
Yao Xue Xue Bao; 2015 Aug; 50(8):1032-7. PubMed ID: 26669005
[TBL] [Abstract][Full Text] [Related]
31. Metabolic changes associated with papillary thyroid carcinoma: A nuclear magnetic resonance-based metabolomics study.
Li Y; Chen M; Liu C; Xia Y; Xu B; Hu Y; Chen T; Shen M; Tang W
Int J Mol Med; 2018 May; 41(5):3006-3014. PubMed ID: 29484373
[TBL] [Abstract][Full Text] [Related]
32. Differential Metabolites in Chinese Autistic Children: A Multi-Center Study Based on Urinary
Ma Y; Zhou H; Li C; Zou X; Luo X; Wu L; Li T; Chen X; Mao M; Huang Y; Li E; An Y; Zhang L; Wang T; Xu X; Yan W; Jiang Y; Wang Y
Front Psychiatry; 2021; 12():624767. PubMed ID: 34045978
[No Abstract] [Full Text] [Related]
33. Quantitative metabolomics of urine for rapid etiological diagnosis of urinary tract infection: evaluation of a microbial-mammalian co-metabolite as a diagnostic biomarker.
Lam CW; Law CY; Sze KH; To KK
Clin Chim Acta; 2015 Jan; 438():24-8. PubMed ID: 25108210
[TBL] [Abstract][Full Text] [Related]
34. NMR-based metabolomic urinalysis: a rapid screening test for urinary tract infection.
Lam CW; Law CY; To KK; Cheung SK; Lee KC; Sze KH; Leung KF; Yuen KY
Clin Chim Acta; 2014 Sep; 436():217-23. PubMed ID: 24909875
[TBL] [Abstract][Full Text] [Related]
35. A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma.
Sahni S; Pandya AR; Hadden WJ; Nahm CB; Maloney S; Cook V; Toft JA; Wilkinson-White L; Gill AJ; Samra JS; Dona A; Mittal A
Int J Cancer; 2021 Mar; 148(6):1508-1518. PubMed ID: 33128797
[TBL] [Abstract][Full Text] [Related]
36. (1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis.
Cocco E; Murgia F; Lorefice L; Barberini L; Poddighe S; Frau J; Fenu G; Coghe G; Murru MR; Murru R; Del Carratore F; Atzori L; Marrosu MG
Neurol Neuroimmunol Neuroinflamm; 2016 Feb; 3(1):e185. PubMed ID: 26740964
[TBL] [Abstract][Full Text] [Related]
37. Serum metabolite profiles of habitual diet: evaluation by 1H-nuclear magnetic resonance analysis.
Lindqvist HM; Rådjursöga M; Malmodin D; Winkvist A; Ellegård L
Am J Clin Nutr; 2019 Jul; 110(1):53-62. PubMed ID: 31127814
[TBL] [Abstract][Full Text] [Related]
38. Noninvasive urinary metabonomic diagnosis of human bladder cancer.
Pasikanti KK; Esuvaranathan K; Ho PC; Mahendran R; Kamaraj R; Wu QH; Chiong E; Chan EC
J Proteome Res; 2010 Jun; 9(6):2988-95. PubMed ID: 20337499
[TBL] [Abstract][Full Text] [Related]
39. Targeted and untargeted urinary metabolic profiling of bladder cancer.
Ossoliński K; Ruman T; Copié V; Tripet BP; Kołodziej A; Płaza-Altamer A; Ossolińska A; Ossoliński T; Nieczaj A; Nizioł J
J Pharm Biomed Anal; 2023 Sep; 233():115473. PubMed ID: 37229797
[TBL] [Abstract][Full Text] [Related]
40. Metabolomic profile of medicinal plants with anti-RVFV activity.
More GK; Vervoort J; Steenkamp PA; Prinsloo G
Heliyon; 2022 Feb; 8(2):e08936. PubMed ID: 35243061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
